<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04034875</url>
  </required_header>
  <id_info>
    <org_study_id>CHUB-SOCIALBI</org_study_id>
    <nct_id>NCT04034875</nct_id>
  </id_info>
  <brief_title>Questionnaire for the Evaluation of Anger, Hostility and Aggression After Acquired Brain Injury.</brief_title>
  <official_title>SOCIALBI, a Rasch Questionnaire for the Evaluation of Anger, Hostility and Aggression After Acquired Brain Injury.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Eric Durand</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Brugmann University Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The incidence of aggression and violent behavior is usually reported to be high after
      acquired brain injury, around 54%. Behaviors with verbal agression and, less frequently,
      physical agressions, are described.

      These behaviors may be linked to the dysfunction of the frontal lobes responsible for
      executive functions and complex social interactions, or to the dysfunction of the temporal
      structures that may also be responsible for increased aggression.

      It is interesting to note that very few scales or specific questionnaires evaluate the
      factors and co-variables that could lead to aggressive behavior after an acquired brain
      injury. Such questionnaires are very rare, and none have been validated in French.

      The objective of this study is to develop a questionnaire in French that aims to assess
      anger, hostility and aggression after acquired brain injury. The psychometric qualities of
      this questionnaire will be evaluated using the Rasch probabilistic model.

      The development of such a tool will be of major interest for clinical practice and future
      clinical research.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">April 9, 2019</start_date>
  <completion_date type="Anticipated">December 2021</completion_date>
  <primary_completion_date type="Anticipated">December 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Questionnaire evaluation by Rasch methodology</measure>
    <time_frame>30 minutes</time_frame>
    <description>questionnaire validity</description>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">50</enrollment>
  <condition>Cerebral Lesion</condition>
  <arm_group>
    <arm_group_label>Patients with acquired brain injury</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Questionnaire</intervention_name>
    <description>questionnaire</description>
    <arm_group_label>Patients with acquired brain injury</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients of the CHU Brugmann Hospital

          -  Central neurological pathology of vascular or traumatic origin, acute or chronic
             (known since more than one year).

        Exclusion Criteria:

          -  Pregnant or lactating women

          -  Presence or antecedents of psychiatric disease

          -  Degenerative pathology (ex: Parkinson...)

          -  Antecedents of other neurologic pathologies before the acquired lesion

          -  Oral or written comprehension dysfunctions.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Eric Durand, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>CHU Brugmann</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Eric Durand, MD</last_name>
    <phone>3224758121</phone>
    <email>Eric.DURAND@chu-brugmann.be</email>
  </overall_contact>
  <location>
    <facility>
      <name>Brugmann University Hospital</name>
      <address>
        <city>Brussels</city>
        <zip>1020</zip>
        <country>Belgium</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Eric Durand, MD</last_name>
      <email>Eric.DURAND@chu-brugmann.be</email>
    </contact>
    <investigator>
      <last_name>Eric Durand, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hôpital Universitaire Pitié-Salpêtrière</name>
      <address>
        <city>Paris</city>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Pradat-Diehl, Pr</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hôpitaux Saint Maurice</name>
      <address>
        <city>Saint-Maurice</city>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Chevignard, MD PhD</last_name>
    </contact>
  </location>
  <location_countries>
    <country>Belgium</country>
    <country>France</country>
  </location_countries>
  <verification_date>July 2019</verification_date>
  <study_first_submitted>July 23, 2019</study_first_submitted>
  <study_first_submitted_qc>July 25, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">July 26, 2019</study_first_posted>
  <last_update_submitted>July 25, 2019</last_update_submitted>
  <last_update_submitted_qc>July 25, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">July 26, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>Brugmann University Hospital</investigator_affiliation>
    <investigator_full_name>Eric Durand</investigator_full_name>
    <investigator_title>Head of clinic (Physical medicine)</investigator_title>
  </responsible_party>
  <keyword>Acquired cerebral lesion</keyword>
  <keyword>Anger</keyword>
  <keyword>Agression</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Brain Injuries</mesh_term>
    <mesh_term>Aggression</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

